Stuart Feinzig Email & Phone Number

Worked in the field within the US Business Unit to support the commercialization pre-launch efforts of Tumor Treating Fields technology for Thoracic Oncology. Responsible for overseeing all Regional Advisory Boards in the US and co-developing the content, strategy, and objectives for each. Collaborated closely with third-party agency partner.*Co-administered the recruiting, development, content, strategy, and execution on both Strategic Council Meetings with key national thoracic advisors. Identified and trained the moderator for both meetings.*Engaged strategic healthcare institutions with a thoracic focus and collaborate to gain insight gathering to support commercial entry into the US thoracic marketplace.*Attended and supported National and Regional oncology conferences to network with key thoracic opinion leaders.*Conducted personal interviews with key academic thoracic leaders to provide a further comprehension on NSCLC pivotal trial design, MOA, opportunities, and obstacles for market entry of a new treatment option.*Supported new and existing customers for the Malignant Pleural Mesothelioma business by engaging regional and national thought leaders with unbranded and corporate materials.

Southeast Region

Launched Optune Lua device in the Southeast region to treat patients with Unresectable Malignant Pleural Mesothelioma.* Key hospital personnel including Medical, Thoracic and Radiation oncology to educate and prescribe the therapy.*Collaborated with the marketing team to identify and develop promotional assets, provide education to aid in the development of training modules and other cross-functional departments to identify collaborative efforts.*Identified key decision-makers within the facility to educate on the device, navigate the Institutional Review Board within the facility, and provide educational support to patients.

Southeast Region

Hired as the first Territory Manager in the Southeast Region with geographical responsibilities in Florida, Georgia, Alabama, and Mississippi. *Introduced and developed educational awareness of TTF as a new technology in recurrent and newly diagnosed GBM into key academic and regional based cancer centers: University of Miami, Moffitt Cancer Center, University of Florida, Mayo, Orlando Health, Florida Hospital, Emory, Piedmont Hospital, University of Alabama and University of Mississippi.*Cultivated key advocates (HCP/AHP) with local/regional spheres of influence, advocacy support groups, and identify and coordinate NovoTAL HCP’s along with maintaining business contracts. *Developed concept and design for Corporate Profile marketing asset which is widely used in the field, shareholder and financial conferences.*Provided strategic and tactical cross-functional collaboration and communication with Medical, Medical Affairs, Marketing, Health Policy, Public Relations and advocacy support.*Fostered relationships with Florida Cancer Specialists and 21st Century Oncology in both corporate offices and private clinic sites throughout South Florida.*Took on responsibility for initiating and advancing the marketplace in Puerto Rico where there are currently eight certified HCP’s and hosted many regional educational programs for physicians and mid-levels. *Developed concept and design for Corporate Profile marketing asset. Awards:Awarded Eastern Territory Manager with highest sales volume, 2016.Recipient of Eastern Division Volume Award 2017 (highest percentage of growth)Southeast Product Team representative 2018. Top Territory Manager Award for sales and volume growth 2018.Promotion to Senior KAM position awarded, 2020.Excellence Award recipient KAM of the Year, 2020.Top US-MPM sales volume with 13 prescription orders, 2020.

Florida, United States

Served as National lead coordinator for an RNA-FUO company based in Israel. Led strategic task force in the development of marketing content, trade show, SOP operations, and reimbursement. Worked on the development of technical marketing assets to serve the targeted audiences of pathology and medical oncology.

Southeast Region

Responsible for the national management of clinical rebate program, communication with cross functional teams and implementing strategic and tactical planning for key oncology GPO accounts including USO, ION (LPP) and Onmark practices. *Covered important oncology state societies including: FLASCO, Alabama Congress Society, Oncology Practice Network, Oncology Managers of Florida and Hematology Oncology Society in Puerto Rico. *Awarded Regional Account Manager for Q1 and Q2 2009, recognized for account and field leadership and creativity.*Earned highest ever RAM quarterly initiative rating of 169% in Q2, 2009. *Developed two Business of Oncology Summit Conferences for FLASCO in October 2009 and October 2010. The 2009 meeting was considered the most significant and successful conference FLASCO has ever hosted.*Created and organized the one-day meeting and had 77 physicians and practice administrators in attendance. Business summit meeting was also exclusively developed for Alabama Society of Clinical Oncology in February 2010*Conceptualized the first Business of Oncology Summit ever hosted in Puerto Rico in September 2010. 72 physicians.*Initiated Best Practice meetings in Florida and Alabama. This meeting was tailored for oncology practice managers to discuss today’s current issues, obstacles and solutions. This was a first-time event at Abraxis Bioscience.

Eastern Region

Developed relationships and advocacy with myelodysplastic syndrome physician thought leaders, professional societies, and patient advocacy organizations within the East Region. *As thought leader, moderated 7 Vidaza Advisory Board meetings. The meetings were designed to attract distinguished clinicians, both academic and community, to advise Pharmion with respect to its medical and marketing strategies. *Created the concept of dinner regional advisory boards for Pharmion. This truncated version of formal advisory boards was a great success as the region completed 44 promotional programs during the 2007 campaign. Assisted in identifying promotional and business opportunities with each clinical account specialist.*Developed myelodysplastic syndrome key thought leaders throughout the region. Clinicians focused on with Pharmion’s educational slide modular library system and identifying speaking opportunities throughout the country.*Co-developed Pharmion’s speaker nominee on-line program. This important template has enabled the advocate development managers to profile and nominate thought leaders into the Pharmion bureau.